Triton Therapeutics
Triton Therapeutics is a startup headquartered in Stamford, United States, founded in 2025. It has raised at least $36.4m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the early stage.
Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .
Funding
Triton Therapeutics has raised at least $36.4m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.
R&D ecosystem
Triton Therapeutics sits inside the New York and New Jersey R&D ecosystem in the Global R&D Labs Directory.
Other startups in Stamford
Related
- Innovation profile of Stamford
- United States: economy and key statistics
- Global Investors Directory
- All 311 Indexes
Questions and answers
What does Triton Therapeutics do?
Triton Therapeutics is classed in pharmaceuticals in its filings with the US Securities and Exchange Commission.
How much has Triton Therapeutics raised?
At least $36.4m, according to its Form D filings with the US Securities and Exchange Commission.
Where is Triton Therapeutics based?
Triton Therapeutics is headquartered in Stamford, United States.
When was Triton Therapeutics founded?
Triton Therapeutics was founded in 2025.
Source record: SEC EDGAR (Form D filings).
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.